Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
BAX 
Baxter International Inc (BAX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: BAX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
18 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $23.8
1 Year Target Price $23.8
| 4 | Strong Buy |
| 2 | Buy |
| 11 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -2.97% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/12/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.84B USD | Price to earnings Ratio - | 1Y Target Price 23.8 |
Price to earnings Ratio - | 1Y Target Price 23.8 | ||
Volume (30-day avg) 18 | Beta 0.61 | 52 Weeks Range 17.39 - 37.25 | Updated Date 12/14/2025 |
52 Weeks Range 17.39 - 37.25 | Updated Date 12/14/2025 | ||
Dividends yield (FY) 3.60% | Basic EPS (TTM) -0.7 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.09% | Operating Margin (TTM) 10.12% |
Management Effectiveness
Return on Assets (TTM) 2.85% | Return on Equity (TTM) -4.66% |
Valuation
Trailing PE - | Forward PE 8.16 | Enterprise Value 17830168665 | Price to Sales(TTM) 0.89 |
Enterprise Value 17830168665 | Price to Sales(TTM) 0.89 | ||
Enterprise Value to Revenue 1.62 | Enterprise Value to EBITDA 17.19 | Shares Outstanding 514055805 | Shares Floating 511994441 |
Shares Outstanding 514055805 | Shares Floating 511994441 | ||
Percent Insiders 0.38 | Percent Institutions 102.7 |
About Baxter International Inc
Exchange NYSE | Headquaters Deerfield, IL, United States | ||
IPO Launch date 1981-10-27 | CEO, President, Interim Group President of Medical Products & Therapies and Director Mr. Andrew P. Hider | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 38000 | Website https://www.baxter.com |
Full time employees 38000 | Website https://www.baxter.com | ||
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.